Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 8.83M P/E - EPS this Y 10.80% Ern Qtrly Grth -
Income -10.06M Forward P/E -0.78 EPS next Y - 50D Avg Chg -17.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -62.00%
Dividend N/A Price/Book 0.83 EPS next 5Y - 52W High Chg -84.00%
Recommedations 2.00 Quick Ratio 3.14 Shares Outstanding 11.04M 52W Low Chg 16.00%
Insider Own 3.15% ROA -82.05% Shares Float 10.68M Beta 1.00
Inst Own 1.18% ROE -156.42% Shares Shorted/Prior 7.55K/48.45K Price 1.18
Gross Margin - Profit Margin - Avg. Volume 55,153 Target Price 11.00
Oper. Margin - Earnings Date May 13 Volume 20,217 Change -2.48%
About ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

ENDRA Life Sciences Inc. News
04/01/24 ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q4 2023 Earnings Call Transcript
03/29/24 Q4 2023 ENDRA Life Sciences Inc Earnings Call
03/28/24 ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
03/21/24 ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024
02/27/24 ENDRA Life Sciences Installs First TAEUS System in the UK
02/21/24 New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences’ TAEUS System
02/14/24 ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe
11/29/23 ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System Technology
11/27/23 ENDRA Life Sciences to Participate in The Benchmark Company’s 12th Annual Discovery One-on-One Investor Conference
11/15/23 ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q3 2023 Earnings Call Transcript
11/14/23 ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update
11/08/23 ENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New Patents
11/07/23 ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023
11/06/23 ENDRA to Host Multidisciplinary Clinical Discussion on Managing Liver Disease During AASLD’s The Liver Meeting® 2023
09/07/23 Abstract for ENDRA Life Sciences' TAEUS System Accepted for Presentation at EASL Steatotic Liver Disease Summit 2023
08/30/23 ENDRA Life Sciences' TAEUS De Novo Submission Advances to Next Stage of Review with FDA
08/23/23 ENDRA Life Sciences Expands Intellectual Property with Issuance of U.S. and European Patents
08/20/23 ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q2 2023 Earnings Call Transcript
08/15/23 Q2 2023 ENDRA Life Sciences Inc Earnings Call
08/14/23 ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update
NDRA Chatroom

User Image rochesterny Posted - 8 hours ago

$NDRA To be accurate you need to mention the product works But yes two failed attempts without fda up or down

User Image Stocktwitsluvsme Posted - 19 hours ago

$NDRA buyer beware. This company has failed 2 submissions miserably. Bold-faced lied to their investors. Misled on timelines as well as kept its investors in the dark about their ongoing business practices. Misled investors to believe they would have sales for their platform. Doesn’t divulge general business practices to its investors. Someone tell me I’m incorrect. Free good advice: DO NOT put a dime in this company.

User Image SBEEE Posted - 1 day ago

$NDRA Wow what a joke👎👎

User Image SBEEE Posted - 2 days ago

$NDRA Wow what happen to Hepa! HEPA has dropped 32.86% to $1.4100. Check it out on Yahoo Finance https://finance.yahoo.com/quote/HEPA?p=HEPA

User Image P_ether Posted - 3 days ago

$NDRA 🚨 SBFM 🚨 BIG GAME GUYS ON MONDAY! CASHLESS WARRANTS- tutes bet massively on dropping the price down with NAKED SHORTS (if they dropped naked short matching warrants, that would be 5x S/O) CANNOT TELL YOU THE BOTTOM, but I can tell with decent certainty that with $1.60/ share , YOU CAN NOT GO WRONG 😁 Btw, S/O is NOW JUST UNDER 1M! LOOK AT THE CHART AND SEE HOW CARELESS HFs(Aegis) WERE! Ask for more details on $SBFM board. Read fillings about last offering warrants!

User Image Buylocal Posted - 4 days ago

$NDRA any retail investor who doesn’t recognize the 96% reduction in stock value, but still wants to buy the new dilutive offer is crazy. Bankruptcy is the only logical path since there is no move to sell the company. BoD clearly is not moving to fire FM.

User Image Buylocal Posted - 4 days ago

$NDRA weird they never mention how many shares are for sale. I’m not a buyer.

User Image SigmundFraud Posted - 4 days ago

@K2019 @WiseAzz $NDRA So let me get this right K, your telling me to get a life, when your entire ST identity was created to post about NDRA. All your post, every single one going back four years, is about NDRA. That seems unnatural and nefarious, when identities are tied to one stock. !

User Image Cheddda Posted - 4 days ago

$NDRA won't be first time or last time someone makes money from a scam stock.

User Image rochesterny Posted - 4 days ago

$NDRA Isn't RS logical near term now

User Image Cheddda Posted - 4 days ago

$NDRA Why not change CEO? Obviously, this one sucks! A new honest CEO can change the trajectory of this company.

User Image SigmundFraud Posted - 5 days ago

$NDRA I can’t believe these scams artist are going to do it again……. They are starting to build a little alumi club of victims! How do they find people to buy into this…… Damn, somebody has got to wear a wire!

User Image WiseAzz Posted - 5 days ago

$NDRA One last final FU to the 🐑 mouthbreathers….. If this “company” was as good at executing the actual business plan as they are with toxic dilution, they’d be in the S&P500. Wild how all those “We Know What We Own” Bulls took their 95% losses n whatever dignity was left and have finally stopped spewing bubble livin moronic rhetoric. Gave ya soooo many opportunities to see the light, but ya couldn’t get out of your own way. #CleetusClipped 🤡

User Image rochesterny Posted - 5 days ago

$NDRA Somewhat of a surprise especially the timing but who will buy

User Image DonCorleone77 Posted - 5 days ago

$NDRA Endra Life Sciences files to sell common stock, warrants, no amount given Craig-Hallum is sole managing underwriter.

User Image Keepitmoving Posted - 5 days ago

$NDRA TAEUS is not a must have even if a) there were no money problems, b) they didn’t totally f*ck up the filing or c) Francois wasn’t a dumb c*nt. Anybody buying shares let alone holding a long position here gets what they deserve. It’s ok to be introspective and admit this was a scam investment. I dumped this trash a long time ago.

User Image Buylocal Posted - 6 days ago

$NDRA in thirty days or less this $0.025

User Image SigmundFraud Posted - 6 days ago

$NDRA Green in a bad market! I’m all in !!!!!!

User Image SBEEE Posted - 6 days ago

$NDRA So did you guys see this new study as of today! https://clinicaltrials.gov/study/NCT06373536?term=Endra&aggFilters=status:&city=&rank=4

User Image BlazerD Posted - 1 week ago

$NDRA dont see how they can dig themselves out of this hole, they need money but at this level they are not going to be able to get it. They will need to do a massive RS and immediately start selling shares which is the most toxic thing you can do to a stock

User Image Rocketr1 Posted - 1 week ago

$NDRA If they actually cared about this company and avoiding another RS or pink sheets they’d PR their plan to quickly build their clinical evidence and when the in person is. Of course they don’t care and are happy sucking their undeserved paychecks as long as they can keep the charade moving.

User Image Keepitmoving Posted - 1 week ago

$NDRA

User Image SigmundFraud Posted - 1 week ago

$NDRA Where’s that Dave guy….. We need a pump!

User Image SBEEE Posted - 1 week ago

$NDRA Another one RIP! https://www.gurufocus.com/insider/119852/michael-milos-thornton

User Image SBEEE Posted - 1 week ago

$NDRA Here is good one!RIP! https://www.gurufocus.com/insider/119854/francois-roger-michelon

User Image SBEEE Posted - 1 week ago

$NDRA 😂😂😂😂😂! https://www1.salary.com/Francois-Michelon-Salary-Bonus-Stock-Options-for-ENDRA-LIFE-SCIENCES-INC.html

User Image SBEEE Posted - 1 week ago

$NDRA Watches and Dreams all shattered! ENDRA ! https://youtu.be/PtBw9sCJR2g?si=5z7jK_nxKu-nOu3B

User Image WiseAzz Posted - 1 week ago

$NDRA But they still did, and lost everything. ☠️ 🤣😘

User Image SigmundFraud Posted - 1 week ago

$NDRA The scam can’t float to the public so they are looking for individual qualified investors to scam….. Be careful boyz…….

User Image SigmundFraud Posted - 1 week ago

$NDRA 0.25/20 =. $0.0125 presplit! Penny stock for sure….. Actually Penny and a quarter!

Analyst Ratings
HC Wainwright & Co. Buy Mar 31, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Thornton Michael Milos Chief Technology Off.. Chief Technology Officer May 18 Buy 1.65 15,000 24,750 34,139 05/22/23
Thornton Michael Milos Chief Technology Off.. Chief Technology Officer Aug 22 Buy 0.27 20,000 5,400 352,775 08/24/22
Tokman Alexander Y Director Director Aug 22 Buy 0.26 20,000 5,200 152,857 08/24/22
Thornton Michael Milos Chief Technology Off.. Chief Technology Officer May 26 Buy 0.21 25,000 5,250 332,775 05/31/22
Michelon Francois Roger Chief Executive Offi.. Chief Executive Officer May 17 Buy 0.19 5,100 969 97,191 05/19/22